RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
EZZ Life Science Holdings Stock

EZZ Life Science Holdings Net Income 2024

EZZ Life Science Holdings Net Income

6.96 M AUD

Ticker

EZZ.AX

ISIN

AU0000130569

In 2024, EZZ Life Science Holdings's profit amounted to 6.96 M AUD, a 91.87% increase from the 3.63 M AUD profit recorded in the previous year.

The EZZ Life Science Holdings Net Income history

YEARNET INCOME (undefined AUD)
2027e4.14
2026e3.87
2025e5.64
20246.96
20233.63
20221.31
20212.03
20201.59
20190.82
2018-

EZZ Life Science Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into EZZ Life Science Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by EZZ Life Science Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects EZZ Life Science Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of EZZ Life Science Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into EZZ Life Science Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing EZZ Life Science Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on EZZ Life Science Holdings’s growth potential.

EZZ Life Science Holdings Revenue, EBIT and net profit per share

DateEZZ Life Science Holdings RevenueEZZ Life Science Holdings EBITEZZ Life Science Holdings Net Income
2027e63.84 M undefined5.23 M undefined4.14 M undefined
2026e59.57 M undefined4.85 M undefined3.87 M undefined
2025e54.17 M undefined7.07 M undefined5.64 M undefined
202466.44 M undefined12.06 M undefined6.96 M undefined
202337.14 M undefined6.41 M undefined3.63 M undefined
202215.02 M undefined3.25 M undefined1.31 M undefined
202122.29 M undefined3.65 M undefined2.03 M undefined
202017.32 M undefined1.71 M undefined1.59 M undefined
201911.19 M undefined1.4 M undefined823,810 undefined
20180 undefined0 undefined0 undefined

EZZ Life Science Holdings stock margins

The EZZ Life Science Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of EZZ Life Science Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for EZZ Life Science Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the EZZ Life Science Holdings's sales revenue. A higher gross margin percentage indicates that the EZZ Life Science Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the EZZ Life Science Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the EZZ Life Science Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the EZZ Life Science Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the EZZ Life Science Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the EZZ Life Science Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

EZZ Life Science Holdings Margin History

EZZ Life Science Holdings Gross marginEZZ Life Science Holdings Profit marginEZZ Life Science Holdings EBIT marginEZZ Life Science Holdings Profit margin
2027e76.68 %8.19 %6.49 %
2026e76.68 %8.14 %6.5 %
2025e76.68 %13.05 %10.41 %
202476.68 %18.15 %10.48 %
202376.81 %17.25 %9.77 %
202249.98 %21.61 %8.74 %
202155.9 %16.38 %9.11 %
202023.26 %9.89 %9.16 %
201939.53 %12.47 %7.36 %
201876.68 %0 %0 %

EZZ Life Science Holdings Aktienanalyse

What does EZZ Life Science Holdings do?

EZZ Life Science Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding EZZ Life Science Holdings's Profit Margins

The profit margins of EZZ Life Science Holdings represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of EZZ Life Science Holdings's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating EZZ Life Science Holdings's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

EZZ Life Science Holdings's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When EZZ Life Science Holdings’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about EZZ Life Science Holdings stock

How much profit has EZZ Life Science Holdings made this year?

EZZ Life Science Holdings has made 6.96 M AUD this year.

How has the profit developed compared to last year?

The profit has increased by 91.87% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does EZZ Life Science Holdings publish its earnings?

EZZ Life Science Holdings publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of EZZ Life Science Holdings?

The profits of EZZ Life Science Holdings are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of EZZ Life Science Holdings?

You can learn more about the earnings of EZZ Life Science Holdings by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does EZZ Life Science Holdings pay?

Over the past 12 months, EZZ Life Science Holdings paid a dividend of 0.05 AUD . This corresponds to a dividend yield of about 1.94 %. For the coming 12 months, EZZ Life Science Holdings is expected to pay a dividend of 0.05 AUD.

What is the dividend yield of EZZ Life Science Holdings?

The current dividend yield of EZZ Life Science Holdings is 1.94 %.

When does EZZ Life Science Holdings pay dividends?

EZZ Life Science Holdings pays a quarterly dividend. This is distributed in the months of June, November, June, December.

How secure is the dividend of EZZ Life Science Holdings?

EZZ Life Science Holdings paid dividends every year for the past 7 years.

What is the dividend of EZZ Life Science Holdings?

For the upcoming 12 months, dividends amounting to 0.05 AUD are expected. This corresponds to a dividend yield of 2.13 %.

In which sector is EZZ Life Science Holdings located?

EZZ Life Science Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von EZZ Life Science Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of EZZ Life Science Holdings from 12/9/2024 amounting to 0.027 AUD, you needed to have the stock in your portfolio before the ex-date on 11/5/2024.

When did EZZ Life Science Holdings pay the last dividend?

The last dividend was paid out on 12/9/2024.

What was the dividend of EZZ Life Science Holdings in the year 2023?

In the year 2023, EZZ Life Science Holdings distributed 0.027 AUD as dividends.

In which currency does EZZ Life Science Holdings pay out the dividend?

The dividends of EZZ Life Science Holdings are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von EZZ Life Science Holdings

Our stock analysis for EZZ Life Science Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of EZZ Life Science Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.